+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Poloxamer Market - Global Forecast 2026-2032- Product Image
Poloxamer Market - Global Forecast 2026-2032- Product Image
Sale

Poloxamer Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124797
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Poloxamer Market is projected to reach USD 193.34 Million in 2026. It is expected to continue growing at a CAGR of 9.03%, reaching USD 324.86 Million by 2032.

Poloxamer Market Introduction and Strategic Context

Poloxamers are nonionic block copolymers of ethylene oxide and propylene oxide used as surfactants, solubilizers, stabilizers, emulsifiers, and thermoresponsive excipients. Their applications span pharmaceutical formulations, drug delivery, biotechnology processing, cosmetics, personal care, and selected industrial uses. Demand is shaped by formulation performance, regulatory requirements, manufacturing consistency, and the need to improve the handling of poorly soluble or sensitive active ingredients.

Transformative Shifts Reshaping Poloxamer Applications

The poloxamer landscape is being transformed by growth in complex formulations, biologics, injectable products, and advanced drug-delivery systems. Manufacturers are placing greater emphasis on low-impurity grades, reproducible critical quality attributes, and excipient traceability. Sustainability is also becoming more relevant, encouraging improvements in solvent use, process efficiency, packaging, and lifecycle documentation. At the same time, tighter regulatory scrutiny is increasing the importance of validated analytical methods and consistent global quality systems.

How Artificial Intelligence Is Influencing Poloxamer Development

Artificial intelligence can support poloxamer innovation by accelerating formulation screening, identifying relationships between polymer characteristics and performance, and helping optimize experimental designs. Machine-learning tools may assist with predicting solubility enhancement, micelle behavior, viscosity, stability, and compatibility with active ingredients. In manufacturing, AI-enabled process monitoring can help detect deviations and improve batch consistency. These benefits depend on reliable, well-curated datasets, laboratory confirmation, explainable models, and compliance with pharmaceutical data-integrity expectations.

Regional Poloxamer Insights Across Six Global Markets

North America is characterized by advanced pharmaceutical development, strong biologics activity, and demanding quality expectations. Europe combines mature pharmaceutical and cosmetic sectors with extensive regulatory and sustainability requirements. Asia-Pacific benefits from expanding drug-manufacturing capabilities, biotechnology investment, and growing formulation capacity, particularly across China, Japan, South Korea, India, and Australia. Latin America is supported by pharmaceutical production and healthcare modernization, while market access can vary by country. The Middle East is developing specialized healthcare and manufacturing capabilities, and Africa presents longer-term opportunities linked to local production, supply-chain resilience, and improved access to medicines.

Poloxamer Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN economies are strengthening pharmaceutical and healthcare supply chains while addressing differences in regulatory maturity and manufacturing capabilities. BRICS members represent diverse industrial, scientific, and healthcare environments, creating opportunities for localized production and technology collaboration alongside complex trade conditions. The European Union emphasizes harmonized quality, environmental compliance, and pharmaceutical safety. G7 countries generally prioritize advanced research, high manufacturing standards, and resilient sourcing. GCC markets are investing in healthcare infrastructure and localization, while NATO members collectively reflect strong demand for dependable medical and industrial supply chains, although procurement requirements remain nationally administered.

Country-Level Poloxamer Conditions in Key National Markets

The United States and Canada have sophisticated pharmaceutical and biotechnology ecosystems with strong demand for validated excipients. Mexico is expanding its role in regional manufacturing and healthcare supply networks. Brazil has a substantial pharmaceutical base and is developing local capabilities, while Russia’s market is influenced by domestic production priorities and access constraints. China combines large-scale chemical and pharmaceutical manufacturing with increasing emphasis on quality upgrading. Japan, South Korea, and Australia support advanced research, regulated healthcare systems, and specialized formulation capabilities. India is a major pharmaceutical manufacturing center with broad formulation expertise. France, Germany, Italy, Spain, and the United Kingdom combine established pharmaceutical, cosmetic, and research sectors, with requirements shaped by European and national regulatory frameworks.

Actions for Leaders Building Resilient Poloxamer Strategies

Industry leaders should segment products by application, grade requirements, and regulatory burden rather than treating poloxamer as a uniform material. They should strengthen dual-source qualification, supplier audits, impurity control, and documentation for critical raw materials. Investment in formulation science should focus on complex injectables, biologics, poorly soluble compounds, and patient-friendly delivery systems. Companies should also establish data governance before deploying AI, connect predictive tools with laboratory validation, and monitor regional regulatory developments. Sustainability initiatives should address manufacturing efficiency, packaging, transport, and end-of-life considerations without compromising product quality or patient safety.

Research Methodology for the Poloxamer Executive Summary

This summary uses a structured review of the poloxamer value chain, including polymer characteristics, application areas, formulation needs, manufacturing considerations, regulatory themes, technology adoption, and geographic conditions. Insights are synthesized from publicly available scientific literature, regulatory materials, technical publications, industry standards, and documented trade and manufacturing information. Findings are presented qualitatively to avoid unsupported market quantification. Regional, group, and country observations reflect differences in industrial capability, healthcare infrastructure, regulatory context, research intensity, and supply-chain resilience.

Conclusion: Strategic Direction for the Poloxamer Industry

Poloxamers remain strategically important because they combine surfactant functionality, formulation flexibility, and compatibility with demanding pharmaceutical and personal-care applications. The strongest opportunities are linked to complex drug products, biologics, advanced delivery systems, and higher-quality excipient management. Success will depend on dependable supply, validated performance, regulatory readiness, responsible use of AI, and disciplined innovation. Leaders that connect formulation science with resilient operations and region-specific execution will be best positioned to respond to evolving customer and compliance requirements.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Poloxamer Market, by Form
7.1. Introduction
7.2. Liquid
7.3. Paste
7.4. Solid
8. Poloxamer Market, by Grade
8.1. Introduction
8.2. Poloxamer 188
8.3. Poloxamer 338
8.4. Poloxamer 407
9. Poloxamer Market, by Molecular Weight
9.1. Introduction
9.2. High (>5000)
9.3. Low (< 2000)
9.4. Medium (2000-5000)
10. Poloxamer Market, by Application
10.1. Introduction
10.2. Household Care
10.3. Industrial
10.4. Personal Care
10.4.1. Hair Care
10.4.2. Oral Care
10.4.3. Skin Care
10.5. Pharmaceutical
10.5.1. Ophthalmic
10.5.2. Oral
10.5.3. Parenteral
10.5.4. Topical
11. Poloxamer Market, by Distribution Channel
11.1. Introduction
11.2. Direct
11.3. Distributor
12. Poloxamer Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Poloxamer Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Poloxamer Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AkzoNobel N.V.
16.2. Ashland Global Holdings Inc.
16.3. BASF SE
16.4. Clariant AG
16.5. Croda International Plc
16.6. Dow Inc.
16.7. Evonik Industries AG
16.8. Innospec Inc.
16.9. Kao Corporation
16.10. Lipo Chemicals Inc.
16.11. Lubrizol Corporation
16.12. Sigma-Aldrich Corporation
16.13. Spectrum Chemical Manufacturing Corp.
16.14. Stepan Company
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Poloxamer Market, Years Considered for the Study
FIGURE 2. Global Poloxamer Market, Research Design
FIGURE 3. Global Poloxamer Market, Research Framework
FIGURE 4. Global Poloxamer Market, Data Triangulation
FIGURE 5. Global Poloxamer Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Poloxamer Market Size, by Form, 2025 vs 2032 (%)
FIGURE 7. Global Poloxamer Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Poloxamer Market Size, by Grade, 2025 vs 2032 (%)
FIGURE 9. Global Poloxamer Market Size, by Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Poloxamer Market Size, by Molecular Weight, 2025 vs 2032 (%)
FIGURE 11. Global Poloxamer Market Size, by Molecular Weight, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Poloxamer Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Poloxamer Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Poloxamer Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Poloxamer Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Poloxamer Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Poloxamer Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Poloxamer Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Poloxamer Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Poloxamer Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Poloxamer Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Poloxamer Market Segmentation & Coverage
TABLE 2. Global Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 3. Global Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 4. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Paste Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Paste Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Paste Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Solid Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Solid Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Solid Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 14. Global Poloxamer 188 Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Poloxamer 188 Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Poloxamer 188 Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Poloxamer 338 Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Poloxamer 338 Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Poloxamer 338 Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Poloxamer 407 Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Poloxamer 407 Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Poloxamer 407 Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 24. Global High (>5000) Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global High (>5000) Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global High (>5000) Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Low (< 2000) Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Low (< 2000) Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Low (< 2000) Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Medium (2000-5000) Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Medium (2000-5000) Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Medium (2000-5000) Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 34. Global Household Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Household Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Household Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Industrial Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Industrial Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Industrial Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Personal Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Personal Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Personal Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Hair Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hair Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hair Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Oral Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Oral Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Oral Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Skin Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Skin Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Skin Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Pharmaceutical Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Pharmaceutical Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Pharmaceutical Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Global Direct Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Direct Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Direct Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. North America Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. North America Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 85. North America Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 86. North America Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 87. North America Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. North America Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 89. North America Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 90. North America Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Latin America Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Latin America Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 93. Latin America Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 94. Latin America Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 95. Latin America Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Latin America Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 97. Latin America Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 98. Latin America Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Europe Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Europe Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 101. Europe Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 102. Europe Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 103. Europe Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Europe Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 105. Europe Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 106. Europe Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Middle East Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Middle East Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 109. Middle East Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 110. Middle East Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 111. Middle East Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Middle East Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 113. Middle East Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 114. Middle East Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Africa Poloxamer Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Africa Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 117. Africa Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 118. Africa Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 119. Africa Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Africa Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 121. Africa Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 122. Africa Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Global Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 126. ASEAN Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 127. ASEAN Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 128. ASEAN Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. ASEAN Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 130. ASEAN Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 131. ASEAN Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. GCC Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. GCC Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 134. GCC Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 135. GCC Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 136. GCC Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. GCC Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 138. GCC Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 139. GCC Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. European Union Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. European Union Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 142. European Union Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 143. European Union Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 144. European Union Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. European Union Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 146. European Union Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 147. European Union Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. BRICS Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. BRICS Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 150. BRICS Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 151. BRICS Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 152. BRICS Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. BRICS Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 154. BRICS Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 155. BRICS Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. G7 Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. G7 Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 158. G7 Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 159. G7 Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 160. G7 Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. G7 Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 162. G7 Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 163. G7 Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. NATO Poloxamer Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. NATO Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 166. NATO Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 167. NATO Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 168. NATO Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. NATO Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 170. NATO Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 171. NATO Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Global Poloxamer Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. United States Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 174. United States Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 175. United States Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 176. United States Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 177. United States Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. United States Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 179. United States Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 180. United States Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Canada Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 182. Canada Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 183. Canada Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 184. Canada Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 185. Canada Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Canada Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 187. Canada Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 188. Canada Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Mexico Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 190. Mexico Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 191. Mexico Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 192. Mexico Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 193. Mexico Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Mexico Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 195. Mexico Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 196. Mexico Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Brazil Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 198. Brazil Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 199. Brazil Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 200. Brazil Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 201. Brazil Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Brazil Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 203. Brazil Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 204. Brazil Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. United Kingdom Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 206. United Kingdom Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 207. United Kingdom Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 208. United Kingdom Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 209. United Kingdom Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. United Kingdom Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 211. United Kingdom Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 212. United Kingdom Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Germany Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 214. Germany Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 215. Germany Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 216. Germany Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 217. Germany Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Germany Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 219. Germany Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 220. Germany Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. France Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 222. France Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 223. France Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 224. France Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 225. France Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. France Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 227. France Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 228. France Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. Russia Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 230. Russia Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 231. Russia Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 232. Russia Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 233. Russia Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Russia Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 235. Russia Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 236. Russia Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Italy Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 238. Italy Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 239. Italy Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 240. Italy Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 241. Italy Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Italy Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 243. Italy Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 244. Italy Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. Spain Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 246. Spain Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 247. Spain Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 248. Spain Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 249. Spain Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Spain Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 251. Spain Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 252. Spain Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. China Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 254. China Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 255. China Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 256. China Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 257. China Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. China Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 259. China Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 260. China Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. India Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 262. India Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 263. India Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 264. India Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 265. India Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. India Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 267. India Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 268. India Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Japan Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 270. Japan Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 271. Japan Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 272. Japan Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 273. Japan Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Japan Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 275. Japan Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 276. Japan Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. Australia Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 278. Australia Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 279. Australia Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 280. Australia Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 281. Australia Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. Australia Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 283. Australia Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 284. Australia Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. South Korea Poloxamer Market Size, 2017-2032 (USD Million)
TABLE 286. South Korea Poloxamer Market Size, by Form, 2017-2032 (USD Million)
TABLE 287. South Korea Poloxamer Market Size, by Grade, 2017-2032 (USD Million)
TABLE 288. South Korea Poloxamer Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 289. South Korea Poloxamer Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. South Korea Poloxamer Market Size, by Personal Care, 2017-2032 (USD Million)
TABLE 291. South Korea Poloxamer Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 292. South Korea Poloxamer Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. Global Poloxamer Market Share, by Key Player, 2025
TABLE 294. Global Poloxamer Market, Key Experts

Companies Mentioned

  • AkzoNobel N.V.
  • Ashland Global Holdings Inc.
  • BASF SE
  • Clariant AG
  • Croda International Plc
  • Dow Inc.
  • Evonik Industries AG
  • Innospec Inc.
  • Kao Corporation
  • Lipo Chemicals Inc.
  • Lubrizol Corporation
  • Sigma-Aldrich Corporation
  • Spectrum Chemical Manufacturing Corp.
  • Stepan Company

Related Topics

Related Reports

Polyethylene Oxide Market - Global Forecast 2026-2032 - Product Image

Polyethylene Oxide Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Polyethylene Glycol Market - Global Forecast 2026-2032 - Product Image

Polyethylene Glycol Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Polyethylene Glycol - Global Strategic Business Report - Product Image

Polyethylene Glycol - Global Strategic Business Report

  • Report
  • 291 Pages
  • Global
From
Polypropylene Glycol - Global Strategic Business Report - Product Image

Polypropylene Glycol - Global Strategic Business Report

  • Report
  • 144 Pages
  • Global
From
Plastics Material and Resin Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA - Product Image

Plastics Material and Resin Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA

  • Report
  • 80 Pages
  • United States
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.